Key result
PEG precipitation resolves false hs-cTnI elevation from macro-troponin I in suspected NSTEMI.
Case Report (n=1)
Persistently elevated hs-cTnI that is discordant with clinical presentation and other cardiac biomarkers should raise suspicion for macro-troponin interference, which can be confirmed using PEG precipitation.
Answers are grounded in this paper and cite their sources.
Clinicians should consider macro-troponin in discordant hs-cTnI elevations; case reports leave open optimal detection strategies and prevalence.
This article reports a clinical case of falsely and significantly elevated high-sensitivity cardiac troponin I (hs-cTnI) levels caused by "Macro-Troponin I". A 54-year-old male patient was admitted with a diagnosis of acute non-ST-segment elevation myocardial infarction (NSTEMI). While his hs-cTnI levels rose sharply during the acute phase and subsequently persisted at an extremely high plateau level (>27404 ng/L) without decline for several days, his myoglobin (MYO) and creatine kinase-MB (CK-MB) levels followed the expected pattern of initial elevation followed by resolution. This discrepancy raised suspicion regarding the validity of the hs-cTnI results. Subsequent systematic laboratory verification, including multi-platform assay comparison revealing a vast discrepancy between hs-cTnI and high-sensitivity cardiac troponin T (hs-cTnT) results, non-linear recovery upon serial dilution, and a marked decrease in hs-cTnI to normal levels after polyethylene glycol (PEG) precipitation, confirmed interference from a precipitable macromolecular complex. Furthermore, the interference could not be eliminated by various common heterophilic antibody blocking agents. Based on laboratory results, we confirmed the presence of a macromolecular interference in the patient’s plasma, which was highly likely to be macro cardiac troponin I due to its ultra-long half-life.Regarding the origin of macro cardiac troponin I, current research indicates that anti-troponin antibodies exist, which rapidly form immune complexes upon exposure to troponin antigens, thereby interfering with experimental data.Through this case, we demonstrated the presence of macro-complexes interference. The patient ultimately received correct diagnosis and management due to timely recognition of this interference.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) conducted a case report in Falsely elevated high-sensitivity cardiac troponin I (n=1). Macro-troponin I was evaluated on High-sensitivity cardiac troponin I (hs-cTnI) levels. Macro-troponin I caused falsely elevated high-sensitivity cardiac troponin I levels (>27,404 ng/L) in a patient with suspected NSTEMI, which were corrected to 148 ng/L following polyethylene glycol precipitation.
Synapse has enriched 10 related papers. Consider them for comparative context: